Pinpointing the molecular targets behind the subjective effects of psychedelic drugs could help clinicians and researchers better treat psychiatric conditions.
Machine learning has pinpointed which neurotransmitter systems and brain regions could be responsible for altered states experienced by patients taking psychedelic drugs.
For the past several decades, psychedelics have been widely stigmatized as dangerous illegal drugs. But a recent surge of academic research into their use to treat psychiatric conditions is spurring a recent shift in public opinion.